Dyne Therapeutics【DYN】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

14.91

買値

14.87

売値

14.94

出来高

99,271

14.76 日の範囲 15.62

14.73 52 週間の範囲 47.45

時価総額

1.517B

前日終値

15.54

始値

15.60

時刻

14.915

最終取引時間

00:16:29

財務取引量

US$ 1,521,023

VWAP

15.3219

平均取引量 (3 か月)

1,228,075

発行済株式数

101,765,958

配当利回り

PER

-6.70

1 株当たり利益 (EPS)

-2.32

歳入

純利益

-235.94M

Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.dyne-tx.com

本社

Wilmington, Delaware, USA

設立

Dyne Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker DYN. The last closing price for Dyne Therapeutics was US$15.54. Over the last year, Dyne Therapeutics shares have traded in a share price range of US$ 14.73 to US$ 47.45.

Dyne Therapeutics currently has 101,765,958 shares in issue. The market capitalisation of Dyne Therapeutics is US$1.58 billion. Dyne Therapeutics has a price to earnings ratio (PE ratio) of -6.70.

Form 8-K - Current report

Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for DYNE-101

- DYNE-101 in DM1: Dyne plans to initiate global Registrational Expansion Cohort of ACHIEVE trial with registrational dose of 6.8 mg/kg Q8W following study data showing splicing correction and...

Dyne Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming...

Dyne Therapeutics to Host Investor Conference Call and Webcast to Review New Clinical Data from the ACHIEVE Trial Friday, January 10 at 8:00 a.m. ET

WALTHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-3.68	-19.7955890264	18.59	19.779	14.73	4581611	15.60688159	CS
4	-9.52	-38.9684813754	24.43	26.22	14.73	1809429	19.02023936	CS
12	-16.29	-52.2115384615	31.2	35.68	14.73	1228075	24.65330047	CS
26	-28.35	-65.5339805825	43.26	47.45	14.73	1207141	31.65234243	CS
52	-1.47	-8.97435897436	16.38	47.45	14.73	1266340	29.67322614	CS
156	7.01	88.7341772152	7.9	47.45	4.3	742135	22.23753018	CS
260	-8.54	-36.4179104478	23.45	47.45	4.3	598589	21.67095017	CS

DYN - Frequently Asked Questions (FAQ)

What is the current Dyne Therapeutics share price?

The current share price of Dyne Therapeutics is US$ 14.91

How many Dyne Therapeutics shares are in issue?

Dyne Therapeutics has 101,765,958 shares in issue

What is the market cap of Dyne Therapeutics?

The market capitalisation of Dyne Therapeutics is USD 1.58B

What is the 1 year trading range for Dyne Therapeutics share price?

Dyne Therapeutics has traded in the range of US$ 14.73 to US$ 47.45 during the past year

What is the PE ratio of Dyne Therapeutics?

The price to earnings ratio of Dyne Therapeutics is -6.7

What is the reporting currency for Dyne Therapeutics?

Dyne Therapeutics reports financial results in USD

What is the latest annual profit for Dyne Therapeutics?

The latest annual profit of Dyne Therapeutics is USD -235.94M

What is the registered address of Dyne Therapeutics?

The registered address for Dyne Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Dyne Therapeutics website address?

The website address for Dyne Therapeutics is www.dyne-tx.com

Which industry sector does Dyne Therapeutics operate in?

Dyne Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

銘柄コード	株価	出来高
BMRABiomerica Inc	US$ 1.0498 (199.94%)	234.28M
DATSDatChat Inc	US$ 6.4401 (51.18%)	24.95M
WHLRWheeler Real Estate Investment Trust Inc	US$ 3.37 (43.40%)	69.31M
ARQQArqit Quantum Inc	US$ 27.50 (33.56%)	1.32M
DOYUDouYu International Holdings Ltd	US$ 15.80 (28.56%)	1.3M
ATRAAtara Biotherapeutics Inc	US$ 7.14 (-45.74%)	878.96k
LUXHLuxUrban Hotels Inc	US$ 0.3988 (-42.04%)	1.33M
LFLYLeafly Holdings Inc	US$ 0.8399 (-41.67%)	206.19k
SHOTWSafety Shot Inc	US$ 0.1501 (-33.29%)	206
PTLEPTL Ltd	US$ 3.07 (-29.43%)	1.38M
ADTXAditxt Inc	US$ 0.144899 (10.61%)	243.03M
BMRABiomerica Inc	US$ 1.0498 (199.94%)	234.28M
ACONAclarion Inc	US$ 0.0459 (8.00%)	189.77M
RGTIRigetti Computing Inc	US$ 11.079 (1.27%)	102.93M
WHLRWheeler Real Estate Investment Trust Inc	US$ 3.37 (43.40%)	69.31M

銘柄コード

株価

出来高